Skip to main content

Table 6 Cost-per averted DALY (USD) by Decrease in PrEP prices and % of non-UAI users stopping Condom use on receiving PrEP

From: Cost utility analysis of HIV pre exposure prophylaxis among men who have sex with men in Israel

% non-UAI stopping condom use Decrease in PrEP prices BEP price decrease
  10% 50% 70% 90%
0% 849,172 472,124 283,601 95,077 87.2%
25% 882,020 493,246 298,859 104,471 88.2%
50% 916,977 515,723 315,096 114,469 89.3%
75% 954,254 539,692 332,410 125,129 90.3%
  1. Notes: Assuming 10% of high-risk users who receive PrEP also start using condoms
  2. Assumes 80% PrEP take up by high-risk MSM,
  3. 25% PrEP take up by low-risk MSM
  4. PrEP efficacy of 86.0% [4, 5]
  5. Based on MOH payment schedule to HMOs for HIV/AIDS patients
  6. BEP = Break Even Point (price decrease) for cost-effectiveness